The Supreme Court on Friday agreed to hear next week the plea of the Indian Medical Association (IMA) which alleged that a smear campaign against the vaccination drive and modern medicines are being conducted in the country.
A bench comprising Chief Justice N V Ramana and Justice Krishna Murari was told by a lawyer, representing the IMA, that a concerted effort is being made to discourage the vaccinations, including the COVID-19 jab drive, and the use of allopathic medicines in the country.
This is a Writ Petition filed by the Indian Medical Association. This is a serious issue as there is a campaign against the vaccination drive and modern medicine in the entire country. The doctors are discouraged. People are misguided to disbelieve medical treatment, the lawyer said.
List it next week, the CJI said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app